Hester Biosciences Limited has informed the Exchange regarding Cessation of Ms. Nina Gandhi as Alternate Director to Mr. Ravin Gandhi w.e.f. May 12, 2026 due to Resignation of Mr. Ravin Gandhi Non- Executive Director.
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr. Ravin Gandhi has resigned as Non-Executive Director of Hester Biosciences Limited effective May 12, 2026. He cited ongoing professional and personal commitments as the reason for his inability to devote sufficient time to the Company's affairs, including attending Board meetings. Ms. Nina Gandhi, who was serving as his Alternate Director, has consequently ceased to hold office on the same date. Mr. Gandhi, based in Chicago, USA, has confirmed that there are no other material reasons for his resignation beyond those stated. The Company has made this disclosure under Regulation 30 of the SEBI LODR Regulations.
The departure of Mr. Ravin Gandhi and his alternate removes a director with family ties from the board. While the company cites personal reasons and no material concerns, investors should monitor whether the board seeks replacement directors to maintain proper governance, especially given the dual departure.